What are the targeted drugs for small cell cancer?
There were several types of targeted drugs for small cell lung cancer: 1. Interferon: It is an anti-virus and anti-tumor immune regulator that can suppress the growth of cancer cells, promote the immune system, enhance immune function, and improve anti-cancer ability. 2. Bendamustine: An oral anti-cancer drug that belongs to the class of egf-alpha inhibition drugs. Compared with traditional chemotherapy drugs, its advantage lies in reducing the patient's side effects while achieving a certain effect. 3. Imatini: an oral targeted drug that can suppress the growth of cancer cells, prolong the survival of patients, and reduce adverse reactions. 4. Perindopril Fumarate: An oral antagonist that mainly targets the growth factors of the blood vessels in the tumor. It suppresses the growth of the blood vessels in the tumor, thereby slowing down the growth of the tumor. 5. Taisheng Qi (Atelizumab): Immune targeting drug. 6. Osimertinib, afartinib, Tarcef, and gefitini were also recommended for targeted treatment of small cell lung cancer. However, the use of targeted drugs needed to be carried out under the guidance of a doctor. At the same time, the treatment of small cell lung cancer needed to take into account the patient's condition and physical condition. Different patients might need to use different drug treatment plans. Read more exciting novels for free
What are the targeted drugs for small cell lung cancer?
Currently, targeted drugs specifically for small cell lung cancer have not been approved for marketing, but there are other types of targeted drugs that can be used to treat small cell lung cancer. For example, anlotinib, a new small-molecular multi-target tropinase inhibition drug, has anti-tumor vasodification effects and has been used in the third-line treatment of small cell lung cancer; Nivaliumab was approved for the treatment of patients with metastasized small cell lung cancer who had previously received platinum-based chemotherapy and at least one other therapy; Drulimucomab can be used in combination with chemotherapy to treat extensive small cell lung cancer; Atelibiza can be used in combination with chemotherapy to treat first-line treatment of extensive small cell lung cancer; There were also apatinib, niraparik, pembrolizib, and so on. In addition, as an anti-viral and anti-tumor immune regulator, Interferon can be used in the treatment of lung cancer; Bendamustine is an egf-receptor antagonist, which can reduce the side effects of patients and achieve a certain effect; Imatini suppresses the growth of cancer cells, prolonging the survival of patients and reducing adverse reactions; Perindopril Fumarate is an oral neo-vasodilator, which can suppress tumor neo-vasodillations and slow down tumor growth. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for the treatment of large B cell cancer?
The targeted drugs commonly used in the clinical treatment of large B-cell leukemia (large B-cell cancer) mainly included rituxed, cyclosporine, iglitinib, and sidariline. Rituanxian is a human-mouse chimera monoclone, which can specifically bind to the membrane protein, CD20. It is suitable for patients with relapsed or drug-resistant B-cell leukemia. It can prolong the patient's progression free survival time and alleviate the resistance of B-cells to cyclosporine. Cyclosporine is a kind of nitrogen mustard drug, which can be converted into the active Metabolite 5 -Phosphates in the body, which plays an anti-tumor role inside and outside the cell. It can be used for the treatment of many malignant tumors, including leukemia. Iglitini was a small molecular anti-tumor targeted drug that could inhibit the RAF kinases on the surface of B cells and the growth of cancer cells. It was suitable for various B-cell lysmphomas, including diffuse large B-cell lysmphoma, etc.; Cedaramin was a kind of nitrogen mustard receptor Tyrosin Kinase Inhibition, which could inhibit tumor cell growth factor receptor, RAF kinases, etc., and had a certain treatment effect on B-cell lysmphoma. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the 32 targeted drugs for treating cancer?
The following are some cancer-targeted drugs: - The targeted drugs for the first-line treatment of lung adenomas and lung cancer with egfr-mutation included osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, and ramulatumab; the second-line treatment (T790M positive) included osimertinib and amitini; the first-line treatment of ALK mutation included alectinib, crizotinib, ceritini, and bugatini; the second-line treatment of crizotinib-resistant included alectinib, bugatinib, and ceritini; and the second-generation targeted drugs included lorlatini. - There were also palinosetron capsules, metoclopramine tablets, ondansetron capsules, and aprepitant capsules. - Larotinib can be used to treat all advanced solid tumors with NtrK gene fusion, including 21 types of cancer, such as thyreoid cancer, myospasm, primary central nervous system tumor, sialoadenoma, Coloembryonic cancer, leukemia, breast cancer, bone sarcomas, histisarcomas, bile duct cancer, hepatic cancer, congenital mesogenic kidney cancer, primary unknown cancer, apexical cancer, liver cancer, bladder cancer, and cervical cancer. However, the number of targeted drugs explicitly mentioned at present did not reach 32, and the complete information of 32 cancer targeted drugs could not be provided. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for liver cancer?
There were mainly the following types of targeted drugs for liver cancer: 1. Sorafenib (Naxavar), covered by medical insurance for patients with unrespavable or distant cancerous tumors. 2. Lenvatini (Levisma) was indicated for patients with unresectable hepatocelluar cancer who had not received prior systematic therapy. 3. Donafenib tosylate tablets (Zepsen) were indicated for patients with unresected liver cancer who had not received prior systematic treatment. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the drugs for cell cancer targeting drugs?
Different types of cell cancer had different targeted drugs: - Target drugs for lung adenomas and lung squamous-cell cancer: - First-line treatment for egf-mutation: osimertinib, dacotinib, gefitini, erlotinib, icotinib, afartinib, bevacidating, ramoisurab; - Second-line therapy for EGFR mutation (T790M positive): osimertinib, amitini; - First-line treatment for ALK mutations: alectinib, crizotinib, ceritini, and bugatini; - Second-line treatment for ALK mutation with crizotinib-resistant drugs: alectinib, bugatini, ceritini; - Resistance to second-generation targeted drugs: Lorlatini; - RET fusion targets: Platini, Saipitini (imported drug). Chinese pharmaceutical companies are also developing related drugs and one of them has achieved good efficacy. There are at least three RET inhibition drugs for clinical trials. - There were three types of targeted therapy drugs for patients with metastasized kidney cell cancer: - Small molecules, such as sorafenib, sunitini, etc., can block the binding of adenosinetrimonates to their corresponding receptor in cells, block the receptor sites of the receptor, and affect tumor vasodilators and cell proliferations; - [Anti-vascular growth factor: Bevaculin is a representative drug that can specifically bind to the blood vessels and block the growth of the blood vessels and the formation of new blood vessels.] - mTO Kinase Inhibition: Representative drugs include everolimus, rapaxin, etc., which can bind to FKBBP12 in the plasma protein and form a complex to inhibit mTO Kinase, thereby suppressing multiple cell signaling pathways and suppressing tumor formation. - Target drugs for hepatocelluar cancer: - Monocentric antibody-type molecular targeted drugs include Herceptin, ritubate, Erbitux, Avastin, etc. - Small molecular compounds were commonly used, such as Gleevc, Iressa, Tarcef, Sorafenib, Androgen, Sunitini, Lapatini, Vandetanil, etc., which had anti-tumor effects on liver cancer, leukemia, and non-small cell lung cancer. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
There are several types of breast cancer targeted drugs
There were mainly the following types of breast cancer targeted drugs: 1. Anti-neoplastic targeted drugs: There are intravenous preparations and oral drugs, but the effect in the treatment of breast cancer is not ideal. For example, bevacidol (Avastin) will be considered in some cases. 2. Anti-Her- 2 targeted drugs: targeted at HER - 2 positive patients, it is the most important targeted drug for breast cancer, mainly including trastuzumab (Herceptin), pertubizab, dm- 1, lapatini, etc. The prerequisite for use was that the patient was positive for HER - 2 (+++ in the immune tissue test). If the immune tissue test was ++, the patient would need to undergo a further FISH test. The patient could only be used if the FISH test was positive. If the immune tissue test was + or-, the patient could not be used. 3. A targeted drug for patients with fetal mutations in the Brca lineage: The main drug is olaparib, which is used to treat patients with metastasizing breast cancer who have harmful or suspected harmful mutations in the Brca lineage and who are negative for the human embryonic growth factor receptor 2 (HEL2). 4. Immune therapy (in a sense, it was also a targeted drug): Anti-PD- 1/PD-L1 Monoclone Antibodies, which essentially relieved immune suppression and activated immune cells to kill cancer cells. 5. mTO inhibition drugs, such as everolimus and sirolimus, can inhibit the activation of the mTO signaling pathway, thereby suppressing the growth and metabolism of tumor cells. 6. Other targeted therapy drugs, such as Parp inhibition drugs, CD 4/6 inhibition drugs, etc. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the names of the drugs used to treat advanced small cell lung cancer?
The drugs used to treat late-stage small cell lung cancer included TaiShengQi (atilibizab), temoziromide, eloposide, irinotecan, platinum, and topographic. Among them, TaiShengQi (atilibizab) was an immune targeting drug; temozuorm could be used as a recommended drug for advanced small cell lung cancer, which had a good effect on the treatment of brain metastasies; Etoposide or irinotecan could be combined with platinum as the first-line chemotherapy scheme, and if the first-line scheme was resistant to the drug, the second line scheme could be selected to be the second line scheme. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
What are the targeted drugs for large B-cell leukemia?
The commonly used targeted drug for large B-cell leukemia was rituxan. It was a large molecular monoclonal-type drug that mainly targeted B-cell leukemia that was positive for CD20. It could be used for first-line treatment of diffuse large B-cell leukemia. There was also odronextamab, which was an anti-CD 3×CD20 bi-specific protein, and mosunetuzan, which also targeted CD3×CD20. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it always effective to take targeted drugs for lung cancer?
The effect of targeted drugs on lung cancer patients was not very good. Target drugs could not cure lung cancer. Although they could prolong survival time, they could not always be effective. There were very few driver mutations in lung cancer, so there were relatively few targeted drugs that could be used. When using targeted drugs, it was necessary to find the target of lung cancer and could not be used blindly. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>
Is it useful to take targeted drugs for esophagus cancer metastasizing?
At present, a variety of targeted drugs were available for the treatment of esophagus cancer, including new small molecules multi-target Tyrosin Kinase Inhibition, drugs that targeted HEL2, cetuxed that targeted the egFr target, and bevacizumb that targeted the veg-like growth factor target, etc. There was also a combination of PD1 - 1 inhibition and targeted HEL2 for the treatment of cancer at the gastric-esophagus junction. Chinese studies have shown that as a new small-molecular multi-target Tyrosinase Kinase Inhibition, anlotinib and apitini have a certain effect in the treatment of esophagus cancer. The combination therapy of trastuzumab-targeted to HEL2 and PD1 inhibition drugs (such as pembrolizumab) combined with chemotherapy can be used as the first-line treatment for cancer of the gastroesophagus junction, advanced gastric cancer with HEL2 positive, and esophagus cancer. In the second-line treatment of China guidelines for the treatment of esophagus cancer, level II recommendations were given to anlotinib (Class 2A) and apitini (Class 3). However, there were no phase III clinical trials to prove that molecular targeted drugs could prolong the survival of patients with esophagus cancer. The effect of targeted therapy needed further study. In general, molecular targeted therapy had a certain clinical value for the treatment of patients with esophagus cancer, including those with metastasizing, but it still needed further in-depth research. These drugs must be used under the guidance of a professional doctor. It is not recommended for patients to buy and take them themselves to avoid serious adverse reactions. <a href="/?from=ask_words" style="color:red" target="_blank">Read more exciting novels for free</a>